Qiming Venture Partners — 2018 Investments
3 investments dated 2018 · listed companies and verified rows first · show all
Madaket operates a SOC 2 Type 2-compliant platform that ingests, standardizes, validates, and synchronizes provider data for the healthcare provider–payer ecosystem.
Data & InfrastructureDigital HealthHealthtechSaaSCambridge, US
James P. Dougherty(Executive Officer, Director)Ted Achtem(Chief Data Officer)inMegan Schmidt(CEO)inJerry Held(Director)Archibald Cox(Director)Jeannine Dahling(Chief Operating Officer)
Board seatGary Rieschel· per SEC Form D
Co-investorsF-Prime CapitalQiming Venture Partners USARaptor GroupWaterline VenturesExperian Ventures
Cadent Therapeutics was a Cambridge, Massachusetts-based neuroscience company developing clinical-stage therapies for neuropsychiatric disorders including schizophrenia, movement disorders, and treatment-resistant depression.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Co-investorsClal Biotechnology IndustriesQiming Venture Partners USASlater Technology FundAccess IndustriesAtlas VentureCowen Healthcare Investments+1 more
Windward delivers AI-powered operational intelligence for maritime security and commercial applications, fusing behavioral analytics and multi-sensor data to detect threats and opportunities.
AI & Machine LearningData & InfrastructureDefense TechTel Aviv
Amiad Daniel(Executive Officer, Director)Matan Peled(Founder)inAmi Daniel(Founder)
BoardDov Gatmon(Director)Patrick Poon(Director)Eden Shochat(Director)in
Co-investorsAlephFTV CapitalThompson Hutton, LLCJanus Henderson InvestorsPivotal Life SciencesQuan Capital+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.










